asco 2023 highlights on nivolumab in advanced stage classic hodgkin lymphoma: the swog s1826 study
Published 1 year ago • 741 plays • Length 5:25Download video MP4
Download video MP3
Similar videos
-
1:49
breakthrough study for advanced stage classic hodgkin lymphoma | asco 2023
-
1:41
swog s1826: nivolumab avd vs brentuximab vedotin avd for advanced stage hodgkin lymphoma
-
6:45
nivolumab chemotherapy in previously untreated stage iii or iv hodgkin lymphoma
-
6:20
asco 2023 highlights on adjuvant osimertinib in resected egfr mutated nsclc: the adaura trial
-
10:42
asco23 - lba4: swog s1826, nivolumab(n)-avd vs. brentuximab vedotin(bv)-avd in advanced stage (a...
-
4:19
asco daily news 2023 plenary update - lba4: swog s1826
-
4:47
asco 2023 highlights on erdafitinib in metastatic urothelial cancer with select fgfr alterations
-
4:47
asco 2023 expert report on novelties in oncogene driven nsclc by a. curioni-fontecedro
-
0:39
highlights at asco 2023
-
1:21
hodgkin lymphoma highlights from ash 2023: nivo-avd versus bv-avd in patients with hl
-
2:14
top highlights from asco & eha 2023
-
1:03:12
best of swog at asco 2023 webinar
-
0:20
lung cancer trial updates at asco 2023
-
1:10
highlights in bladder cancer from asco 2022
-
47:21
asco 2023: highlights and analysis
-
2:19
update from asco 2023 – lymphoma & myeloma connect